Treatment of vestibular vertigo using botulinum toxins
AssigneePenland Foundation
InventorRoland M. Williams
Life of this patent
Estimating the term…
Abstract
A method of treating vertigo in a patient in need thereof comprises administering a botulinum toxin to the patient. The botulinum toxin may be administered by subcutaneous/intradermal injection. The subcutaneous/intradermal injection may be administered to and/or around the vicinity of a trigeminal nerve, a cervical nerve, a thoracic nerve, a lumbar nerve, and a sacral nerve of the patient.
Claims9
A method of treating vestibular vertigo in a patient in need thereof, comprising administering a botulinum toxin to the patient, wherein the administering for a patient comprises by subcutaneous or intradermal injection 2-4 units to and/or around the vicinity of trigeminal nerve, 2-4 units to and/or around the vicinity of a cervical nerve, lateral to the spine, 2-4 units to and/or around the vicinity of a thoracic nerve, lateral to the spine, 2-4 unit to and/or around the vicinity of a lumbar nerve, lateral to the spine, and/or 2-4 units to and/or around the vicinity of a sacral nerve, lateral to the spine, wherein each of the subcutaneous or intradermal injections is bilateral.
Dependencies are inferred from the claim text.